Michele Pagano

Dr. Michele Pagano, MD, is the Chair of the Department of Biochemistry and Molecular Pharmacology and the May Ellen and Gerald Jay Ritter Professor of Oncology at the New York University School of Medicine, and an Investigator of the Howard Hughes Medical Institute. Dr. Pagano received his doctorate in Medicine and a specialty diploma in Molecular Endocrinology in 1990 from the Federico II University in his native Napoli, Italy. He was subsequently a post-doctoral fellow at EMBL, Heidelberg, Germany (1990-92), before co-founding Mitotix Inc. (1992-96). He joined the NYU School of Medicine in 1996. Dr. Pagano has received many prestigious grants including a MERIT Award (2006-2017) from the National Cancer Institute in recognition of his outstanding achievements in cancer biology. Dr. Pagano’s research focuses on the kinases and ubiquitylating enzymes that control cell proliferation and how deregulation of these machineries contribute to malignant transformation.